Skip to content

Cingulate Inc.

CING· NasdaqCore metricsCIK 1862150

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -1.97%
Market cap
$66.28M
14.76M shares
Filings
497
—
—
—
-$7.73M
Q3 2026N/M FY25 yoy
-$7.49M
Q3 2026N/M FY25 yoy
-$20.41M
Q3 2026derivedN/M FY25 yoy
-$0.53
Q3 2026N/M FY25 yoy
$23.19M
Q3 2026−10.3% FY25 yoy
$66.28M
—
—
3.2×
-26.26%
—

FY2025 figures · derived

Price

$4.49+22.34%+$0.82past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Total Interest and Dividend Income

$93.03KQ2 2025
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

Cingulate Inc. is the 314th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Cingulate Inc. · CIK 1862150 · Engraved from SEC EDGAR